Acadia Healthcare Co Inc

Acadia Healthcare insider buy: director Cancelmi Daniel J’s modest 6,625‑share purchase signals renewed confidence amid market turbulence and behavioral‑health sector challenges.

Farley Brian’s recent insider sale at Acadia Healthcare shows routine small‑scale divestment, not a red flag, and offers investors insight into executive liquidity needs and confidence amid steady earnings and moderate profitability.

Acadia Healthcare CEO grants zero‑cost stock option with vesting milestones at $25–$45, signaling confidence in a price rebound and aligning her interests with long‑term shareholder value.